Skip to main content

Advertisement

Table 1 Clinicopathological characteristics of the patients cohort (n = 101)

From: Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients

Characteristics   n %
Tumor histotype Ductal 92 91.1
Lobular 7 6.9
Others 2 2.0
Tumor T1c 27 26.7
T2 45 44.6
T3 4 4.0
T4 25 24.7
Lymph nodes N0 34 33.7
N1 32 31.7
N2 15 14.8
N3 20 19.8
Metastases Absent 90 89.1
Present 11 10.9
Stage I 15 14.8
II 45 44.6
III 30 29.7
IV 11 10.9
ER status Negative 38 37.6
Positive 63 62.4
PgR status Negative 50 49.5
Positive 51 50.5
HER2 amplification Negative 66 65.3
Positive 30 29.7
Missing 5 5.0
Receptor Classification Receptor positive 63 62.4
Triple Negative 20 19.8
Her2/neu amplified 18 17.8
Grade G1 11 10.8
G2 38 37.7
G3 40 39.6
Missing 12 11.9
First metastatic site Bone 19 46.4
Lung 11 26.8
Brain 6 14.6
Liver 2 4.9
Others 3 7.3
NPI Low Risk 16 18.0
Intermediate Risk 43 48.3
High Risk 30 33.7
Adjuvant therapy* HT + CT 53 58.9
CT 18 20.0
Ct + anti-HER2 16 17.8
HT 2 2.2
  None 1 1.1
  1. *HT, Hormone Therapy; CT, Chemotherapy.